223 related articles for article (PubMed ID: 21686223)
1. Clinical utility and development of biomarkers in invasive aspergillosis.
Patterson TF
Trans Am Clin Climatol Assoc; 2011; 122():174-83. PubMed ID: 21686223
[TBL] [Abstract][Full Text] [Related]
2. The future of animal models of invasive aspergillosis.
Patterson TF
Med Mycol; 2005 May; 43 Suppl 1():S115-9. PubMed ID: 16110802
[TBL] [Abstract][Full Text] [Related]
3. [Aspergillus in airway material : Ignore or treat?].
Salzer HJF; Lange C; Hönigl M
Internist (Berl); 2017 Nov; 58(11):1150-1162. PubMed ID: 28986661
[TBL] [Abstract][Full Text] [Related]
4. Advances in diagnostic testing.
Verweij PE
Med Mycol; 2005 May; 43 Suppl 1():S121-4. PubMed ID: 16110803
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients.
Badiee P; Alborzi A; Karimi M; Pourabbas B; Haddadi P; Mardaneh J; Moieni M
J Infect Dev Ctries; 2012 Apr; 6(4):352-7. PubMed ID: 22505446
[TBL] [Abstract][Full Text] [Related]
6. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
[TBL] [Abstract][Full Text] [Related]
7. The current management landscape: aspergillosis.
Maertens JA; Blennow O; Duarte RF; Muñoz P
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii23-ii29. PubMed ID: 27880666
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?
Buchheidt D; Reinwald M; Spiess B; Boch T; Hofmann WK; Groll AH; Lehrnbecher T;
Mycoses; 2016 Feb; 59(2):67-74. PubMed ID: 26756571
[TBL] [Abstract][Full Text] [Related]
9. Invasive aspergillosis in kidney transplant recipients: a cohort study.
Pérez-Sáez MJ; Mir M; Montero MM; Crespo M; Montero N; Gómez J; Horcajada JP; Pascual J
Exp Clin Transplant; 2014 Apr; 12(2):101-5. PubMed ID: 24702140
[TBL] [Abstract][Full Text] [Related]
10. Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis.
Wiederhold NP; Thornton CR; Najvar LK; Kirkpatrick WR; Bocanegra R; Patterson TF
Clin Vaccine Immunol; 2009 Dec; 16(12):1844-6. PubMed ID: 19793899
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
12. Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
Miceli MH; Maertens J
Semin Respir Crit Care Med; 2015 Oct; 36(5):650-61. PubMed ID: 26398532
[TBL] [Abstract][Full Text] [Related]
13. Chronic invasive aspergillosis caused by Aspergillus viridinutans.
Vinh DC; Shea YR; Jones PA; Freeman AF; Zelazny A; Holland SM
Emerg Infect Dis; 2009 Aug; 15(8):1292-4. PubMed ID: 19751595
[TBL] [Abstract][Full Text] [Related]
14. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
Schwarzinger M; Sagaon-Teyssier L; Cabaret O; Bretagne S; Cordonnier C;
PLoS One; 2013; 8(6):e65776. PubMed ID: 23799048
[TBL] [Abstract][Full Text] [Related]
15. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.
Petraitiene R; Petraitis V; Bacher JD; Finkelman MA; Walsh TJ
Med Mycol; 2015 Aug; 53(6):558-68. PubMed ID: 26129890
[TBL] [Abstract][Full Text] [Related]
16. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
Thornton C; Johnson G; Agrawal S
J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
18. Invasive pulmonary aspergillosis in heart transplant recipients.
Küpeli E; Ulubay G; Bayram Akkurt S; Öner Eyüboğlu F; Sezgin A
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():352-5. PubMed ID: 25894189
[TBL] [Abstract][Full Text] [Related]
19. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia.
Paholcsek M; Fidler G; Konya J; Rejto L; Mehes G; Bukta E; Loeffler J; Biro S
BMC Infect Dis; 2015 Jul; 15():251. PubMed ID: 26126706
[TBL] [Abstract][Full Text] [Related]
20. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Danylo A; Courtemanche C; Pelletier R; Boudreault AA
Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
